CA
NZ
UK
AU
IND
US
…
Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Delivra Health Brands Inc. is an OTCQB-listed company with limited public disclosure that appears positioned in the consumer health and wellness sector, focused on branded products and distribution. Long-term growth drivers may include expanding its brand portfolio, scaling distribution channels and rising consumer demand for health-oriented goods, which could support revenue growth for a small-cap consolidator. Investors may find exposure to potential brand consolidation attractive if management can execute on commercialization and distribution plans.
Material risks include limited public information and low liquidity typical of OTC listings, execution risk on brand acquisitions and commercialization, intense competition in consumer health, and regulatory and product‑safety compliance requirements.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Income before tax | 0.88M | -0.18M | -7.01M | -22.67M | -62.77M |
| Minority interest | - | - | - | 0.00M | 1.54M |
| Net income | 0.88M | -0.18M | -7.01M | -28.54M | -79.86M |
| Selling general administrative | 5.80M | 4.86M | 6.50M | 8.89M | 16.42M |
| Gross profit | 6.40M | 4.82M | 2.60M | 1.92M | -0.63M |
| Reconciled depreciation | 1.31M | 1.33M | 2.12M | 2.66M | 3.07M |
| Ebit | - | -1.36M | -6.01M | -9.26M | -14.11M |
| Ebitda | - | - | -4.25M | -6.60M | -58.89M |
| Operating income | -0.71M | -1.36M | -6.01M | -9.26M | -19.72M |
| Interest expense | 0.17M | 0.25M | 0.64M | - | 0.80M |
| Interest income | - | - | - | 0.04M | - |
| Net interest income | -0.17M | -0.25M | -0.64M | 0.04M | -0.80M |
| Total revenue | 12.38M | 9.79M | 8.14M | 7.96M | 8.38M |
| Total operating expenses | 13.09M | 11.15M | 14.15M | 17.22M | 28.11M |
| Cost of revenue | 5.98M | 4.97M | 5.54M | 6.04M | 9.02M |
| Total other income expense net | 1.75M | 1.43M | -0.36M | -13.45M | -42.24M |
| Discontinued operations | - | - | - | -5.87M | -22.66M |
| Net income from continuing ops | 0.88M | -0.18M | -7.01M | -22.67M | -62.77M |
| Net income applicable to common shares | - | -0.18M | -7.01M | -28.54M | -79.86M |
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Total assets | 10.05M | 10.56M | 11.59M | 19.06M | 57.84M |
| Intangible assets | 1.19M | 2.47M | 3.67M | 6.03M | 12.63M |
| Other current assets | - | - | 2.34M | - | 15.05M |
| Total liab | 4.86M | 7.17M | 8.21M | 9.09M | 21.27M |
| Total stockholder equity | 5.19M | 3.39M | 3.37M | 9.98M | 33.52M |
| Other current liab | - | 0.72M | 0.59M | 0.54M | 1.61M |
| Common stock | - | 148.23M | 148.23M | 148.23M | 146.20M |
| Capital stock | 148.63M | 148.23M | 148.23M | 148.23M | 146.20M |
| Retained earnings | -169.16M | -170.04M | -169.85M | -162.84M | -134.31M |
| Good will | - | - | - | - | 0.00M |
| Other assets | - | - | 0.15M | 0.29M | 0.40M |
| Cash | 4.20M | 2.72M | 1.08M | 4.43M | 1.41M |
| Total current liabilities | 3.07M | 5.47M | 6.54M | 7.24M | 19.19M |
| Net debt | - | - | 1.02M | - | 4.57M |
| Short long term debt | 0.24M | 0.25M | 0.44M | 0.31M | 3.89M |
| Other stockholder equity | - | 25.20M | 25.00M | 24.60M | 21.62M |
| Property plant equipment | - | 0.18M | 0.27M | 2.91M | 16.39M |
| Total current assets | 8.76M | 7.92M | 7.49M | 9.84M | 28.41M |
| Long term investments | - | - | - | - | 0.00M |
| Net tangible assets | - | 0.92M | -0.30M | 3.94M | 20.88M |
| Short term investments | 0.00M | 0.01M | 0.03M | 0.71M | - |
| Net receivables | 2.69M | 2.74M | 1.71M | 2.14M | 1.77M |
| Long term debt | 1.78M | 1.70M | 1.67M | 1.85M | 2.08M |
| Inventory | 1.48M | 2.26M | 2.22M | 2.28M | 9.29M |
| Accounts payable | 0.71M | 2.19M | 3.58M | 4.87M | 10.74M |
| Non current assets total | 1.29M | 2.65M | 4.10M | 9.23M | 29.43M |
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Investments | 0.01M | 2.91M | 1.27M | 1.03M | 1.26M |
| Change to liabilities | - | 0.04M | -0.69M | -6.04M | -0.03M |
| Total cashflows from investing activities | - | 2.91M | 1.35M | 12.27M | -3.64M |
| Net borrowings | -0.23M | -0.26M | -0.31M | -4.08M | 3.17M |
| Total cash from financing activities | 0.59M | -0.26M | -0.31M | 0.45M | 3.17M |
| Change to operating activities | - | -0.08M | 0.33M | 0.40M | 0.50M |
| Net income | 0.88M | -0.18M | -7.01M | -28.54M | -79.86M |
| Change in cash | 1.48M | 1.64M | -3.35M | 3.02M | -18.89M |
| Begin period cash flow | 2.72M | 1.08M | 4.43M | 1.41M | 20.30M |
| End period cash flow | 4.20M | 2.72M | 1.08M | 4.43M | 1.41M |
| Total cash from operating activities | 0.76M | -1.09M | -4.44M | -9.65M | -18.36M |
| Issuance of capital stock | 0.82M | - | 0.00M | 4.49M | - |
| Depreciation | 1.31M | 1.29M | 2.08M | 2.22M | 2.70M |
| Change to inventory | 0.52M | -0.47M | -0.72M | 2.27M | -6.37M |
| Change to account receivables | - | -0.87M | -0.23M | 1.12M | 2.02M |
| Change to netincome | - | -0.86M | 1.76M | 18.92M | 62.66M |
| Capital expenditures | 0.00M | 0.04M | 0.01M | 0.03M | 6.29M |
| Change in working capital | -0.20M | -1.38M | -1.31M | -2.25M | -3.87M |
| Stock based compensation | 0.03M | 0.15M | 0.35M | 0.58M | 2.02M |
| Other non cash items | 0.28M | 0.07M | 0.25M | 0.96M | 1.63M |
| Free cash flow | 0.76M | -1.13M | -4.46M | -9.68M | -24.67M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DHBUF Delivra Health Brands Inc |
- -% |
0.06 | - | 3.62 | 0.37 | 1.48 | 0.26 | 10.08 |
| MKKGY Merck KGaA ADR |
0.32 0.99% |
32.57 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
158.72 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
-0.18 0.91% |
20.09 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
-3.18 7.73% |
37.97 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Frank A. Holler MBA | Independent Exec. Chairman | 1957 |
| Mr. Gord Davey | Pres, CEO & Director | NA |
| Mr. Jack Z. Tasse C.M.A., CPA | CFO & Corp. Sec. | NA |
| Mr. Matthew Wagar | Sr. VP of Marketing & Innovation | NA |
| Ms. Ann Gallery | Sr. VP of Corp. Communications | NA |
| Mr. Will Stewart | Sr. VP of Corp. & Public Affairs | 1976 |
| Mr. Christopher Podolsky CA, CPA | Advisor | NA |
| Mr. Jonathan David Hartshorn | Pres & CEO of Satipharm | 1970 |
| Mr. Kwong Choo CGA, CPA | VP of Fin. | 1964 |
| Mr. Frank A. Holler MBA | Independent Executive Chairman | 1957 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.43%
Communication Services
-0.80%
Consumer Cyclical
-0.28%
Consumer Defensive
-0.47%
Energy
+0.39%
Financial Services
-0.37%
Financials
-0.92%
Healthcare
+0.69%
Industrials
+0.14%
Real Estate
-0.41%
Technology
+0.14%
Utilities
-0.27%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...